Physician profile
Eva Khavkin
NPI 1306884978
$4,681.42
in general payments reported to CMS, 2019-2025
12 companies · $656 in 2025
The $656 reported for 2025 was more than what 75% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,429 · 2020: $294 · 2021: $406 · 2022: $587 · 2023: $900 · 2024: $408 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,460.01 | 2019-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Neurocrine Biosciences, INC. | $1,099.66 | 2019-2024 | Ingrezza |
| Avanir Pharmaceuticals, INC. | $609.00 | 2019-2022 | |
| Abbvie INC. | $375.00 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $277.72 | 2019-2022 | |
| Allergan, INC. | $249.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $146.42 | 2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $139.75 | 2025 | Fanapt |
| Alkermes, INC. | $125.00 | 2025 | Lybalvi |
| Axsome Therapeutics, INC. | $120.51 | 2023 | Auvelity |
| Nestle Healthcare Nutrition INC. | $51.99 | 2022 | |
| Aimmune Therapeutics, INC. | $26.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Khavkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.